| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | L-leucine binding | 1.85e-04 | 7 | 60 | 2 | GO:0070728 | |
| GeneOntologyBiologicalProcess | keratinization | 1.04e-07 | 87 | 54 | 6 | GO:0031424 | |
| GeneOntologyBiologicalProcess | epidermis development | 2.81e-06 | 461 | 54 | 9 | GO:0008544 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 8.87e-06 | 284 | 54 | 7 | GO:0009913 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 9.80e-06 | 189 | 54 | 6 | GO:0030216 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | JAG2 ERBB4 KRT28 LCE5A LCE1C LCE1B LCE1F NOTCH2 LCE2A PROC LCE3C | 1.28e-05 | 870 | 54 | 11 | GO:0030855 |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process via the N-end rule pathway | 4.02e-05 | 4 | 54 | 2 | GO:0071596 | |
| GeneOntologyBiologicalProcess | skin development | 5.10e-05 | 373 | 54 | 7 | GO:0043588 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature morphogenesis | 1.00e-04 | 6 | 54 | 2 | GO:0072103 | |
| GeneOntologyBiologicalProcess | glomerular capillary formation | 1.00e-04 | 6 | 54 | 2 | GO:0072104 | |
| GeneOntologyBiologicalProcess | renal system vasculature morphogenesis | 1.40e-04 | 7 | 54 | 2 | GO:0061438 | |
| GeneOntologyBiologicalProcess | kidney vasculature morphogenesis | 1.40e-04 | 7 | 54 | 2 | GO:0061439 | |
| GeneOntologyBiologicalProcess | cell fate determination | 3.05e-04 | 50 | 54 | 3 | GO:0001709 | |
| GeneOntologyBiologicalProcess | epithelium development | JAG2 ERBB4 TNC KRT28 LCE5A LCE1C LCE1B LCE1F NOTCH2 LCE2A PROC LCE3C | 3.38e-04 | 1469 | 54 | 12 | GO:0060429 |
| GeneOntologyBiologicalProcess | glomerulus morphogenesis | 3.64e-04 | 11 | 54 | 2 | GO:0072102 | |
| GeneOntologyBiologicalProcess | mitochondrial fragmentation involved in apoptotic process | 4.37e-04 | 12 | 54 | 2 | GO:0043653 | |
| GeneOntologyCellularComponent | intermediate filament | KRTAP5-9 KRTAP2-3 KRTAP13-3 KRTAP2-4 KRT28 KRTAP21-3 KRTAP1-3 KRTAP5-1 KRTAP5-4 KRTAP5-3 KRTAP5-10 KRTAP2-1 KRTAP15-1 KRTAP5-5 KRTAP5-7 KRTAP5-11 | 1.59e-18 | 227 | 59 | 16 | GO:0005882 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRTAP5-9 KRTAP2-3 KRTAP13-3 KRTAP2-4 KRT28 KRTAP21-3 KRTAP1-3 KRTAP5-1 KRTAP5-4 KRTAP5-3 KRTAP5-10 KRTAP2-1 KRTAP15-1 KRTAP5-5 KRTAP5-7 KRTAP5-11 | 1.69e-17 | 263 | 59 | 16 | GO:0045111 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRTAP5-9 KRTAP2-3 KRTAP13-3 KRTAP2-4 KRT28 KRTAP21-3 KRTAP1-3 KRTAP5-1 KRTAP5-4 KRTAP5-3 KRTAP5-10 KRTAP2-1 KRTAP15-1 KRTAP5-5 KRTAP5-7 KRTAP5-11 | 2.31e-09 | 899 | 59 | 16 | GO:0099513 |
| GeneOntologyCellularComponent | supramolecular polymer | KRTAP5-9 COL4A6 KRTAP2-3 KRTAP13-3 KRTAP2-4 KRT28 KRTAP21-3 KRTAP1-3 KRTAP5-1 KRTAP5-4 KRTAP5-3 KRTAP5-10 KRTAP2-1 KRTAP15-1 KRTAP5-5 KRTAP5-7 KRTAP5-11 | 1.70e-08 | 1187 | 59 | 17 | GO:0099081 |
| GeneOntologyCellularComponent | supramolecular fiber | KRTAP5-9 KRTAP2-3 KRTAP13-3 KRTAP2-4 KRT28 KRTAP21-3 KRTAP1-3 KRTAP5-1 KRTAP5-4 KRTAP5-3 KRTAP5-10 KRTAP2-1 KRTAP15-1 KRTAP5-5 KRTAP5-7 KRTAP5-11 | 1.04e-07 | 1179 | 59 | 16 | GO:0099512 |
| GeneOntologyCellularComponent | tenascin complex | 4.68e-05 | 4 | 59 | 2 | GO:0090733 | |
| GeneOntologyCellularComponent | keratin filament | 1.63e-04 | 97 | 59 | 4 | GO:0045095 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 1.04e-03 | 17 | 59 | 2 | GO:0098637 | |
| GeneOntologyCellularComponent | extracellular matrix | 2.40e-03 | 656 | 59 | 7 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 2.45e-03 | 658 | 59 | 7 | GO:0030312 | |
| MousePheno | abnormal brain thrombosis | 4.08e-05 | 4 | 37 | 2 | MP:0031168 | |
| Domain | KAP | KRTAP5-9 KRTAP2-3 KRTAP2-4 KRTAP1-3 KRTAP5-1 KRTAP5-4 KRTAP5-3 KRTAP5-10 KRTAP2-1 KRTAP2-2 KRTAP5-5 KRTAP5-7 KRTAP5-11 | 3.46e-21 | 58 | 61 | 13 | IPR002494 |
| Domain | Keratin_B2 | KRTAP5-9 KRTAP2-3 KRTAP2-4 KRTAP1-3 KRTAP5-4 KRTAP2-1 KRTAP2-2 KRTAP5-5 KRTAP5-11 | 5.77e-15 | 40 | 61 | 9 | PF01500 |
| Domain | EGF | SCARF1 JAG2 STAB2 FCGBP MEGF6 TNC MATN1 CNTNAP3 TENM2 TNXB MEGF11 NOTCH2 NOTCH3 PROC | 2.25e-14 | 235 | 61 | 14 | SM00181 |
| Domain | EGF-like_dom | SCARF1 JAG2 STAB2 FCGBP MEGF6 TNC MATN1 CNTNAP3 TENM2 TNXB MEGF11 NOTCH2 NOTCH3 PROC | 5.01e-14 | 249 | 61 | 14 | IPR000742 |
| Domain | EGF_3 | SCARF1 JAG2 STAB2 MEGF6 TNC MATN1 CNTNAP3 TENM2 TNXB MEGF11 NOTCH2 NOTCH3 PROC | 5.47e-13 | 235 | 61 | 13 | PS50026 |
| Domain | EGF_1 | SCARF1 JAG2 STAB2 MEGF6 TNC MATN1 CNTNAP3 TENM2 TNXB MEGF11 NOTCH2 NOTCH3 PROC | 1.55e-12 | 255 | 61 | 13 | PS00022 |
| Domain | EGF-like_CS | SCARF1 JAG2 STAB2 MEGF6 TNC MATN1 CNTNAP3 TENM2 TNXB MEGF11 NOTCH2 NOTCH3 PROC | 2.08e-12 | 261 | 61 | 13 | IPR013032 |
| Domain | EGF_2 | SCARF1 JAG2 STAB2 MEGF6 TNC MATN1 CNTNAP3 TENM2 TNXB MEGF11 NOTCH2 NOTCH3 PROC | 2.52e-12 | 265 | 61 | 13 | PS01186 |
| Domain | EGF | 9.17e-12 | 126 | 61 | 10 | PF00008 | |
| Domain | LCE | 1.13e-11 | 17 | 61 | 6 | PF14672 | |
| Domain | LCE | 1.13e-11 | 17 | 61 | 6 | IPR028205 | |
| Domain | EGF_extracell | 1.80e-11 | 60 | 61 | 8 | IPR013111 | |
| Domain | EGF_2 | 1.80e-11 | 60 | 61 | 8 | PF07974 | |
| Domain | SPRR/LCE | 3.36e-10 | 28 | 61 | 6 | IPR026075 | |
| Domain | Growth_fac_rcpt_ | 1.88e-09 | 156 | 61 | 9 | IPR009030 | |
| Domain | Keratin_B2_2 | 2.83e-09 | 39 | 61 | 6 | PF13885 | |
| Domain | EGF_CA | 5.80e-09 | 122 | 61 | 8 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 6.59e-09 | 124 | 61 | 8 | IPR001881 | |
| Domain | hEGF | 2.92e-08 | 28 | 61 | 5 | PF12661 | |
| Domain | Laminin_EGF | 6.99e-06 | 38 | 61 | 4 | IPR002049 | |
| Domain | EGF_CA | 8.94e-06 | 86 | 61 | 5 | PF07645 | |
| Domain | ClpS_core | 1.05e-05 | 2 | 61 | 2 | IPR003769 | |
| Domain | ClpS | 1.05e-05 | 2 | 61 | 2 | PF02617 | |
| Domain | EGF_Ca-bd_CS | 1.61e-05 | 97 | 61 | 5 | IPR018097 | |
| Domain | EGF_CA | 1.78e-05 | 99 | 61 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 1.87e-05 | 100 | 61 | 5 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.47e-05 | 106 | 61 | 5 | IPR000152 | |
| Domain | - | 3.14e-05 | 3 | 61 | 2 | 3.30.1390.10 | |
| Domain | DUF3454 | 3.14e-05 | 3 | 61 | 2 | PF11936 | |
| Domain | Ribosomal_L7/12_C/ClpS-like | 3.14e-05 | 3 | 61 | 2 | IPR014719 | |
| Domain | DUF3454_notch | 3.14e-05 | 3 | 61 | 2 | IPR024600 | |
| Domain | DUF3454 | 3.14e-05 | 3 | 61 | 2 | SM01334 | |
| Domain | NOD | 6.27e-05 | 4 | 61 | 2 | PF06816 | |
| Domain | Notch | 6.27e-05 | 4 | 61 | 2 | IPR008297 | |
| Domain | NODP | 6.27e-05 | 4 | 61 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 6.27e-05 | 4 | 61 | 2 | IPR011656 | |
| Domain | Notch_NOD_dom | 6.27e-05 | 4 | 61 | 2 | IPR010660 | |
| Domain | NOD | 6.27e-05 | 4 | 61 | 2 | SM01338 | |
| Domain | NODP | 6.27e-05 | 4 | 61 | 2 | SM01339 | |
| Domain | LNR | 1.04e-04 | 5 | 61 | 2 | PS50258 | |
| Domain | FBG | 1.14e-04 | 29 | 61 | 3 | SM00186 | |
| Domain | - | 1.26e-04 | 30 | 61 | 3 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 1.26e-04 | 30 | 61 | 3 | IPR014716 | |
| Domain | Fibrinogen_a/b/g_C_dom | 1.54e-04 | 32 | 61 | 3 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 1.54e-04 | 32 | 61 | 3 | PS51406 | |
| Domain | FIBRINOGEN_C_1 | 1.54e-04 | 32 | 61 | 3 | PS00514 | |
| Domain | Laminin_EGF | 2.01e-04 | 35 | 61 | 3 | PF00053 | |
| Domain | EGF_Lam | 2.01e-04 | 35 | 61 | 3 | SM00180 | |
| Domain | Notch_dom | 2.18e-04 | 7 | 61 | 2 | IPR000800 | |
| Domain | Notch | 2.18e-04 | 7 | 61 | 2 | PF00066 | |
| Domain | zf-UBR | 2.18e-04 | 7 | 61 | 2 | PF02207 | |
| Domain | Znf_UBR | 2.18e-04 | 7 | 61 | 2 | IPR003126 | |
| Domain | ZnF_UBR1 | 2.18e-04 | 7 | 61 | 2 | SM00396 | |
| Domain | NL | 2.18e-04 | 7 | 61 | 2 | SM00004 | |
| Domain | ZF_UBR | 2.18e-04 | 7 | 61 | 2 | PS51157 | |
| Domain | PMG | 8.00e-04 | 13 | 61 | 2 | PF05287 | |
| Domain | KRTAP_PMG | 8.00e-04 | 13 | 61 | 2 | IPR007951 | |
| Domain | EMI_domain | 1.22e-03 | 16 | 61 | 2 | IPR011489 | |
| Domain | ANK | 1.36e-03 | 251 | 61 | 5 | SM00248 | |
| Domain | EMI | 1.38e-03 | 17 | 61 | 2 | PS51041 | |
| Domain | ANK_REPEAT | 1.41e-03 | 253 | 61 | 5 | PS50088 | |
| Domain | ANK_REP_REGION | 1.43e-03 | 254 | 61 | 5 | PS50297 | |
| Domain | Ankyrin_rpt | 1.64e-03 | 262 | 61 | 5 | IPR002110 | |
| Domain | VWC_out | 1.73e-03 | 19 | 61 | 2 | SM00215 | |
| Domain | Quino_amine_DH_bsu | 2.32e-03 | 22 | 61 | 2 | IPR011044 | |
| Domain | - | 2.77e-03 | 24 | 61 | 2 | 4.10.530.10 | |
| Domain | Fibrinogen_a/b/g_C_2 | 2.77e-03 | 24 | 61 | 2 | IPR014715 | |
| Domain | Fibrinogen_C | 3.49e-03 | 27 | 61 | 2 | PF00147 | |
| Domain | Ank_2 | 5.34e-03 | 215 | 61 | 4 | PF12796 | |
| Pathway | REACTOME_KERATINIZATION | KRTAP5-9 KRTAP2-3 KRTAP13-3 KRTAP2-4 KRT28 KRTAP21-3 KRTAP1-3 LCE5A KRTAP5-1 KRTAP5-4 KRTAP5-3 KRTAP5-10 KRTAP2-1 KRTAP2-2 KRTAP15-1 LCE1C LCE1B KRTAP5-5 LCE1F KRTAP5-7 KRTAP5-11 LCE2A LCE3C | 4.67e-29 | 217 | 50 | 23 | M27640 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRTAP5-9 KRTAP2-3 KRTAP13-3 KRTAP2-4 KRT28 KRTAP21-3 KRTAP1-3 LCE5A KRTAP5-1 KRTAP5-4 KRTAP5-3 KRTAP5-10 KRTAP2-1 KRTAP2-2 KRTAP15-1 LCE1C LCE1B KRTAP5-5 LCE1F KRTAP5-7 KRTAP5-11 LCE2A LCE3C | 8.72e-11 | 1432 | 50 | 23 | M509 |
| Pathway | REACTOME_KERATINIZATION | KRTAP2-3 KRTAP13-3 KRTAP2-4 KRT28 KRTAP1-3 KRTAP5-4 KRTAP2-1 KRTAP2-2 KRTAP5-5 | 2.83e-09 | 153 | 50 | 9 | MM15343 |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 3.29e-07 | 129 | 50 | 7 | M27649 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 1.17e-05 | 13 | 50 | 3 | M47423 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRTAP2-3 KRTAP13-3 KRTAP2-4 KRT28 KRTAP1-3 KRTAP5-4 KRTAP2-1 KRTAP2-2 KRTAP5-5 | 5.84e-05 | 502 | 50 | 9 | MM14537 |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 1.16e-04 | 27 | 50 | 3 | M39545 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 1.22e-04 | 5 | 50 | 2 | M27411 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.49e-04 | 76 | 50 | 4 | M27219 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 1.83e-04 | 6 | 50 | 2 | M27068 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 5.36e-04 | 45 | 50 | 3 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 5.72e-04 | 46 | 50 | 3 | MM15971 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 6.10e-04 | 47 | 50 | 3 | MM14925 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 6.10e-04 | 47 | 50 | 3 | M7946 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 6.64e-04 | 11 | 50 | 2 | M47865 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 7.95e-04 | 12 | 50 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 7.95e-04 | 12 | 50 | 2 | M47533 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 9.38e-04 | 13 | 50 | 2 | M47534 | |
| Pathway | PID_NOTCH_PATHWAY | 1.19e-03 | 59 | 50 | 3 | M17 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.26e-03 | 15 | 50 | 2 | MM14922 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 1.31e-03 | 61 | 50 | 3 | M39540 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 1.82e-03 | 18 | 50 | 2 | M614 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 2.03e-03 | 19 | 50 | 2 | MM15594 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.14e-03 | 258 | 50 | 5 | MM14572 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 2.25e-03 | 20 | 50 | 2 | M15394 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 2.51e-03 | 161 | 50 | 4 | M39770 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 2.72e-03 | 22 | 50 | 2 | M27210 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.97e-03 | 23 | 50 | 2 | M15997 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION | 2.97e-03 | 23 | 50 | 2 | M14766 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.97e-03 | 23 | 50 | 2 | MM1427 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION | 2.97e-03 | 23 | 50 | 2 | MM14557 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 3.05e-03 | 82 | 50 | 3 | MM15922 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 3.24e-03 | 24 | 50 | 2 | M11190 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.27e-03 | 84 | 50 | 3 | M7098 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 3.51e-03 | 25 | 50 | 2 | M27879 | |
| Pathway | WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3 | 3.61e-03 | 87 | 50 | 3 | M39465 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 4.39e-03 | 28 | 50 | 2 | M6177 | |
| Pubmed | KRTAP5-9 KRTAP5-1 KRTAP5-4 KRTAP5-3 KRTAP5-10 KRTAP5-5 KRTAP5-7 KRTAP5-11 | 8.15e-20 | 13 | 62 | 8 | 15144888 | |
| Pubmed | Assessment of community efforts to advance network-based prediction of protein-protein interactions. | KRTAP5-9 KRTAP2-3 CRCT1 KRTAP2-4 KRT28 KRTAP1-3 LCE5A KRTAP5-1 KRTAP5-4 KRTAP5-3 KRTAP15-1 LCE1C LCE1B LCE1F KRTAP5-7 KRTAP5-11 LCE2A LCE3C | 3.06e-17 | 630 | 62 | 18 | 36949045 |
| Pubmed | 1.98e-13 | 16 | 62 | 6 | 17410201 | ||
| Pubmed | 1.83e-12 | 22 | 62 | 6 | 15854049 | ||
| Pubmed | Differentially expressed late constituents of the epidermal cornified envelope. | 2.47e-12 | 23 | 62 | 6 | 11698679 | |
| Pubmed | 6.37e-09 | 37 | 62 | 5 | 11279113 | ||
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 5.38e-08 | 5 | 62 | 3 | 15064243 | |
| Pubmed | 5.38e-08 | 5 | 62 | 3 | 16899352 | ||
| Pubmed | 1.57e-07 | 69 | 62 | 5 | 18721477 | ||
| Pubmed | 1.88e-07 | 7 | 62 | 3 | 10383933 | ||
| Pubmed | 1.88e-07 | 7 | 62 | 3 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 1.88e-07 | 7 | 62 | 3 | 12846471 | |
| Pubmed | CYSRT1: An Antimicrobial Epidermal Protein that Can Interact with Late Cornified Envelope Proteins. | 1.88e-07 | 7 | 62 | 3 | 36804407 | |
| Pubmed | 1.88e-07 | 7 | 62 | 3 | 16169548 | ||
| Pubmed | 3.00e-07 | 8 | 62 | 3 | 12475935 | ||
| Pubmed | P4 down-regulates Jagged2 and Notch1 expression during primordial folliculogenesis. | 3.00e-07 | 8 | 62 | 3 | 22652674 | |
| Pubmed | 3.00e-07 | 8 | 62 | 3 | 9858718 | ||
| Pubmed | 3.00e-07 | 8 | 62 | 3 | 11044610 | ||
| Pubmed | 4.50e-07 | 9 | 62 | 3 | 11118901 | ||
| Pubmed | 4.50e-07 | 9 | 62 | 3 | 16245338 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 6.42e-07 | 10 | 62 | 3 | 23665443 | |
| Pubmed | Jag2-Notch1 signaling regulates oral epithelial differentiation and palate development. | 8.81e-07 | 11 | 62 | 3 | 16607638 | |
| Pubmed | 8.81e-07 | 11 | 62 | 3 | 10878608 | ||
| Pubmed | 8.81e-07 | 11 | 62 | 3 | 12866128 | ||
| Pubmed | 1.17e-06 | 12 | 62 | 3 | 15465494 | ||
| Pubmed | Jagged1 is Essential for Radial Glial Maintenance in the Cortical Proliferative Zone. | 1.52e-06 | 13 | 62 | 3 | 31202705 | |
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 1.52e-06 | 13 | 62 | 3 | 11578869 | |
| Pubmed | 1.94e-06 | 14 | 62 | 3 | 14757642 | ||
| Pubmed | 2.42e-06 | 15 | 62 | 3 | 17194759 | ||
| Pubmed | 2.42e-06 | 15 | 62 | 3 | 12971992 | ||
| Pubmed | 2.42e-06 | 15 | 62 | 3 | 9291577 | ||
| Pubmed | Lunatic fringe, FGF, and BMP regulate the Notch pathway during epithelial morphogenesis of teeth. | 2.42e-06 | 15 | 62 | 3 | 12167404 | |
| Pubmed | COUP-TFI controls Notch regulation of hair cell and support cell differentiation. | 2.42e-06 | 15 | 62 | 3 | 16914494 | |
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 2.97e-06 | 16 | 62 | 3 | 12617809 | |
| Pubmed | 2.97e-06 | 16 | 62 | 3 | 10842072 | ||
| Pubmed | 2.97e-06 | 16 | 62 | 3 | 17273555 | ||
| Pubmed | The Cellular Prion Protein Controls Notch Signaling in Neural Stem/Progenitor Cells. | 2.97e-06 | 16 | 62 | 3 | 27641601 | |
| Pubmed | 2.97e-06 | 16 | 62 | 3 | 32161758 | ||
| Pubmed | Bound Waters Mediate Binding of Diverse Substrates to a Ubiquitin Ligase. | 3.13e-06 | 2 | 62 | 2 | 28392261 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 9321695 | ||
| Pubmed | Role of N-end rule ubiquitin ligases UBR1 and UBR2 in regulating the leucine-mTOR signaling pathway. | 3.13e-06 | 2 | 62 | 2 | 20298436 | |
| Pubmed | Expression of notch family proteins in placentas from patients with early-onset severe preeclampsia. | 3.13e-06 | 2 | 62 | 2 | 24336671 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 34257585 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 16606826 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 8856503 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 16311597 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 15548684 | ||
| Pubmed | Effects of Notch2 and Notch3 on Cell Proliferation and Apoptosis of Trophoblast Cell Lines. | 3.13e-06 | 2 | 62 | 2 | 26640406 | |
| Pubmed | Invasion of melanoma in double knockout mice lacking tenascin-X and tenascin-C. | 3.13e-06 | 2 | 62 | 2 | 12359049 | |
| Pubmed | Notch2 and Notch3 function together to regulate vascular smooth muscle development. | 3.13e-06 | 2 | 62 | 2 | 22615991 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 17202312 | ||
| Pubmed | Structural basis of substrate recognition and specificity in the N-end rule pathway. | 3.13e-06 | 2 | 62 | 2 | 20835242 | |
| Pubmed | The change in tenascin expression in mouse uterus during early pregnancy. | 3.13e-06 | 2 | 62 | 2 | 9013311 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 15455729 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 7509489 | ||
| Pubmed | The effects of tenascin C knockdown on trabecular meshwork outflow resistance. | 3.13e-06 | 2 | 62 | 2 | 23882691 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 12496659 | ||
| Pubmed | 3.60e-06 | 17 | 62 | 3 | 18694942 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 3.60e-06 | 17 | 62 | 3 | 15821257 | |
| Pubmed | Lunatic fringe null female mice are infertile due to defects in meiotic maturation. | 4.32e-06 | 18 | 62 | 3 | 15659488 | |
| Pubmed | 4.32e-06 | 18 | 62 | 3 | 18093989 | ||
| Pubmed | 4.32e-06 | 18 | 62 | 3 | 15689374 | ||
| Pubmed | 5.12e-06 | 19 | 62 | 3 | 16518823 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 6.77e-06 | 560 | 62 | 8 | 21653829 | |
| Pubmed | 7.01e-06 | 21 | 62 | 3 | 28656980 | ||
| Pubmed | Conversion of biliary system to pancreatic tissue in Hes1-deficient mice. | 7.01e-06 | 21 | 62 | 3 | 14702043 | |
| Pubmed | 8.11e-06 | 22 | 62 | 3 | 21750033 | ||
| Pubmed | 9.31e-06 | 23 | 62 | 3 | 14701881 | ||
| Pubmed | 9.31e-06 | 23 | 62 | 3 | 24337118 | ||
| Pubmed | Notch signaling drives multiple myeloma induced osteoclastogenesis. | 9.37e-06 | 3 | 62 | 2 | 25257302 | |
| Pubmed | Expression of tenascin in developing and adult mouse lymphoid organs. | 9.37e-06 | 3 | 62 | 2 | 7687262 | |
| Pubmed | p32 regulates mitochondrial morphology and dynamics through parkin. | 9.37e-06 | 3 | 62 | 2 | 22008525 | |
| Pubmed | Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas. | 9.37e-06 | 3 | 62 | 2 | 19147558 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 7530141 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 7615640 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 7918097 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 8645602 | ||
| Pubmed | Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. | 9.37e-06 | 3 | 62 | 2 | 7694605 | |
| Pubmed | Expression of Notch1 to -4 and their ligands in renal cell carcinoma: a tissue microarray study. | 9.37e-06 | 3 | 62 | 2 | 21471519 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 27697639 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 15317757 | ||
| Pubmed | Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction. | 9.37e-06 | 3 | 62 | 2 | 18458347 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 37209968 | ||
| Pubmed | Overlapping but distinct roles for NOTCH receptors in human cardiovascular disease. | 9.37e-06 | 3 | 62 | 2 | 29767458 | |
| Pubmed | The dynamic expression of tenascin-C and tenascin-X during early heart development in the mouse. | 9.37e-06 | 3 | 62 | 2 | 12823230 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 7698746 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 27717083 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 25957400 | ||
| Pubmed | Identification of Ubr1 as an amino acid sensor of steatosis in liver and muscle. | 9.37e-06 | 3 | 62 | 2 | 37057345 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 28572448 | ||
| Pubmed | The Notch-mediated circuitry in the evolution and generation of new cell lineages: the tooth model. | 9.37e-06 | 3 | 62 | 2 | 37330998 | |
| Pubmed | Rbpj regulates development of prosensory cells in the mammalian inner ear. | 1.06e-05 | 24 | 62 | 3 | 21420948 | |
| Pubmed | 1.36e-05 | 26 | 62 | 3 | 15454262 | ||
| Pubmed | Notch signaling controls liver development by regulating biliary differentiation. | 1.36e-05 | 26 | 62 | 3 | 19369401 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 14585983 | ||
| Pubmed | Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer. | 1.87e-05 | 4 | 62 | 2 | 28061457 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 24145721 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 20069356 | ||
| Pubmed | Expression and clinical significance of Notch receptors in human renal cell carcinoma. | 1.87e-05 | 4 | 62 | 2 | 19404845 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 28669409 | ||
| Interaction | KRTAP5-11 interactions | KRTAP5-9 KRTAP2-3 CRCT1 KRTAP13-3 KRTAP2-4 KRTAP1-3 LCE5A KRTAP15-1 LCE1C LCE1B LCE1F KRTAP5-7 KRTAP5-11 LCE2A LCE3C | 4.59e-25 | 66 | 60 | 15 | int:KRTAP5-11 |
| Interaction | KRTAP9-2 interactions | KRTAP5-9 POTEB3 KRTAP2-3 CRCT1 KRTAP13-3 KRTAP2-4 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 KRTAP15-1 LCE1C LCE1B LCE1F KRTAP5-7 KRTAP5-11 LCE2A LCE3C | 1.07e-24 | 149 | 60 | 18 | int:KRTAP9-2 |
| Interaction | KRTAP4-11 interactions | KRTAP5-9 POTEB3 KRTAP2-3 CRCT1 KRTAP2-4 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 KRTAP15-1 LCE1C LCE1B LCE1F KRTAP5-7 LCE2A LCE3C | 1.15e-24 | 92 | 60 | 16 | int:KRTAP4-11 |
| Interaction | KRTAP4-4 interactions | KRTAP5-9 KRTAP2-3 CRCT1 KRTAP2-4 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-7 KRTAP5-11 LCE2A LCE3C | 1.35e-23 | 81 | 60 | 15 | int:KRTAP4-4 |
| Interaction | KRTAP5-2 interactions | KRTAP5-9 KRTAP2-3 CRCT1 KRTAP2-4 LCE5A KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-7 KRTAP5-11 LCE2A LCE3C | 2.19e-23 | 62 | 60 | 14 | int:KRTAP5-2 |
| Interaction | LCE1A interactions | KRTAP5-9 KRTAP2-3 CRCT1 KRTAP2-4 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-7 KRTAP5-11 LCE2A LCE3C | 2.44e-23 | 84 | 60 | 15 | int:LCE1A |
| Interaction | LCE1F interactions | KRTAP5-9 KRTAP2-3 CRCT1 KRTAP2-4 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-7 KRTAP5-11 LCE2A LCE3C | 1.06e-22 | 92 | 60 | 15 | int:LCE1F |
| Interaction | KRTAP10-1 interactions | KRTAP5-9 KRTAP2-3 CRCT1 KRTAP13-3 KRTAP2-4 KRTAP1-3 LCE5A KRTAP5-1 KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-7 KRTAP5-11 LCE2A LCE3C | 1.09e-22 | 153 | 60 | 17 | int:KRTAP10-1 |
| Interaction | LCE1D interactions | SCARF1 KRTAP5-9 KRTAP2-3 CRCT1 KRTAP2-4 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-11 LCE2A | 1.43e-22 | 70 | 60 | 14 | int:LCE1D |
| Interaction | KRTAP5-6 interactions | KRTAP5-9 CRCT1 KRTAP13-3 KRTAP1-3 LCE5A KRTAP5-1 KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-7 KRTAP5-11 LCE2A LCE3C | 1.50e-22 | 94 | 60 | 15 | int:KRTAP5-6 |
| Interaction | LCE2B interactions | KRTAP5-9 KRTAP2-3 CRCT1 KRTAP2-4 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-7 LCE2A LCE3C | 1.32e-21 | 81 | 60 | 14 | int:LCE2B |
| Interaction | LCE1B interactions | KRTAP5-9 KRTAP2-3 KRTAP2-4 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-7 KRTAP5-11 LCE2A LCE3C | 2.72e-21 | 85 | 60 | 14 | int:LCE1B |
| Interaction | KRTAP5-4 interactions | KRTAP5-9 CRCT1 KRTAP1-3 LCE5A KRTAP5-1 KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-7 LCE2A LCE3C | 3.35e-21 | 63 | 60 | 13 | int:KRTAP5-4 |
| Interaction | LCE2C interactions | KRTAP5-9 KRTAP2-3 CRCT1 KRTAP2-4 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-7 KRTAP5-11 LCE2A | 4.58e-21 | 88 | 60 | 14 | int:LCE2C |
| Interaction | LCE2A interactions | KRTAP5-9 KRTAP2-3 CRCT1 KRTAP2-4 KRTAP1-3 LCE5A KRTAP5-4 LCE1C LCE1B LCE1F KRTAP5-7 KRTAP5-11 LCE2A | 1.22e-20 | 69 | 60 | 13 | int:LCE2A |
| Interaction | KRTAP9-8 interactions | KRTAP5-9 KRTAP2-3 CRCT1 KRTAP2-4 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-11 LCE2A LCE3C | 3.06e-20 | 100 | 60 | 14 | int:KRTAP9-8 |
| Interaction | LCE2D interactions | KRTAP5-9 KRTAP2-3 KRTAP2-4 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-7 LCE2A LCE3C | 3.27e-20 | 74 | 60 | 13 | int:LCE2D |
| Interaction | KRTAP4-5 interactions | KRTAP5-9 POTEB3 CRCT1 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-7 LCE2A LCE3C | 4.76e-20 | 76 | 60 | 13 | int:KRTAP4-5 |
| Interaction | KRTAP9-3 interactions | KRTAP5-9 KRTAP2-3 CRCT1 KRTAP13-3 KRTAP2-4 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-11 LCE2A LCE3C | 8.00e-20 | 140 | 60 | 15 | int:KRTAP9-3 |
| Interaction | LCE4A interactions | KRTAP5-9 CRCT1 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-7 KRTAP5-11 LCE2A LCE3C | 9.73e-20 | 80 | 60 | 13 | int:LCE4A |
| Interaction | LCE5A interactions | KRTAP5-9 KRTAP2-3 KRTAP2-4 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-11 LCE2A LCE3C | 4.96e-19 | 90 | 60 | 13 | int:LCE5A |
| Interaction | KRTAP5-3 interactions | KRTAP5-9 CRCT1 KRTAP1-3 LCE5A KRTAP5-1 KRTAP5-4 KRTAP5-3 KRTAP15-1 LCE1C LCE1B LCE1F LCE3C | 6.55e-19 | 66 | 60 | 12 | int:KRTAP5-3 |
| Interaction | KRTAP4-12 interactions | KRTAP5-9 KRTAP2-3 CRCT1 KRTAP2-4 KRTAP1-3 LCE5A KRTAP5-1 KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-7 LCE2A LCE3C | 6.92e-19 | 161 | 60 | 15 | int:KRTAP4-12 |
| Interaction | LCE3B interactions | KRTAP5-9 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-7 KRTAP5-11 LCE2A | 7.60e-19 | 46 | 60 | 11 | int:LCE3B |
| Interaction | LCE1E interactions | KRTAP5-9 KRTAP2-3 KRTAP2-4 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-7 KRTAP5-11 | 9.64e-19 | 68 | 60 | 12 | int:LCE1E |
| Interaction | LCE1C interactions | KRTAP5-9 KRTAP2-3 CRCT1 KRTAP2-4 LCE5A KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-11 LCE2A | 4.77e-18 | 77 | 60 | 12 | int:LCE1C |
| Interaction | HOXA1 interactions | JAG2 KRTAP5-9 KRTAP2-3 MEGF6 KRTAP13-3 KRTAP2-4 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 KRTAP15-1 LCE1C LCE1B LCE1F KRTAP5-11 LCE2A NOTCH3 LCE3C | 8.61e-18 | 356 | 60 | 18 | int:HOXA1 |
| Interaction | KRTAP5-9 interactions | KRTAP5-9 POTEB3 KRTAP2-3 CRCT1 KRTAP2-4 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-11 LCE2A LCE3C | 2.36e-17 | 203 | 60 | 15 | int:KRTAP5-9 |
| Interaction | KRTAP10-11 interactions | KRTAP5-9 CRCT1 KRTAP13-3 KRTAP1-3 LCE5A LCE1C LCE1B LCE1F KRTAP5-7 LCE2A LCE3C | 4.07e-17 | 64 | 60 | 11 | int:KRTAP10-11 |
| Interaction | LCE3C interactions | KRTAP5-9 KRTAP2-3 KRTAP2-4 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 LCE1B LCE1F KRTAP5-11 LCE3C | 6.98e-17 | 67 | 60 | 11 | int:LCE3C |
| Interaction | KRTAP4-2 interactions | KRTAP5-9 CRCT1 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-7 KRTAP5-11 LCE2A LCE3C | 8.88e-17 | 132 | 60 | 13 | int:KRTAP4-2 |
| Interaction | CYSRT1 interactions | SCARF1 KRTAP5-9 KRTAP2-3 CRCT1 KRTAP13-3 KRTAP2-4 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 KRTAP15-1 LCE1C LCE1B LCE1F KRTAP5-7 KRTAP5-11 LCE2A PROC LCE3C | 2.67e-16 | 511 | 60 | 19 | int:CYSRT1 |
| Interaction | LCE3A interactions | KRTAP5-9 KRTAP2-3 CRCT1 KRTAP2-4 KRTAP1-3 KRTAP5-4 KRTAP5-3 LCE1C KRTAP5-7 KRTAP5-11 LCE2A | 3.05e-16 | 76 | 60 | 11 | int:LCE3A |
| Interaction | VASN interactions | JAG2 KRTAP2-3 KRTAP2-4 KRTAP1-3 LCE5A KRTAP5-4 LCE1C LCE1B LCE1F KRTAP5-11 NOTCH2 LCE2A LCE3C | 1.14e-15 | 160 | 60 | 13 | int:VASN |
| Interaction | KRTAP10-5 interactions | KRTAP5-9 CRCT1 KRTAP2-4 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-11 LCE2A LCE3C | 1.14e-15 | 160 | 60 | 13 | int:KRTAP10-5 |
| Interaction | CRCT1 interactions | KRTAP5-9 CRCT1 KRTAP1-3 KRTAP5-4 KRTAP5-3 LCE1C LCE1F KRTAP5-7 KRTAP5-11 LCE2A | 4.61e-15 | 66 | 60 | 10 | int:CRCT1 |
| Interaction | RGS17 interactions | CRCT1 LCE5A KRTAP5-4 KRTAP5-3 LCE1B LCE1F KRTAP5-11 LCE2A LCE3C | 1.50e-14 | 48 | 60 | 9 | int:RGS17 |
| Interaction | OTX1 interactions | KRTAP5-9 KRTAP2-3 KRTAP13-3 KRTAP2-4 KRTAP1-3 KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-11 LCE2A | 2.83e-14 | 155 | 60 | 12 | int:OTX1 |
| Interaction | CREB5 interactions | KRTAP5-9 KRTAP2-3 KRTAP2-4 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 LCE1C LCE1F KRTAP5-7 KRTAP5-11 LCE2A | 5.61e-14 | 164 | 60 | 12 | int:CREB5 |
| Interaction | LCE3E interactions | KRTAP5-9 KRTAP2-3 KRTAP2-4 KRTAP1-3 KRTAP5-4 KRTAP5-3 KRTAP5-7 KRTAP5-11 LCE2A | 1.29e-13 | 60 | 60 | 9 | int:LCE3E |
| Interaction | KRTAP2-3 interactions | KRTAP5-9 KRTAP2-3 KRTAP2-4 LCE5A LCE1C LCE1B LCE1F KRTAP5-11 LCE2A LCE3C | 2.07e-13 | 95 | 60 | 10 | int:KRTAP2-3 |
| Interaction | KRTAP10-9 interactions | KRTAP5-9 CRCT1 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-7 KRTAP5-11 LCE2A LCE3C | 2.32e-13 | 241 | 60 | 13 | int:KRTAP10-9 |
| Interaction | KRTAP2-4 interactions | KRTAP5-9 KRTAP2-3 KRTAP2-4 LCE5A LCE1C LCE1B LCE1F KRTAP5-11 LCE2A LCE3C | 3.88e-13 | 101 | 60 | 10 | int:KRTAP2-4 |
| Interaction | LCE3D interactions | KRTAP5-9 KRTAP2-3 KRTAP2-4 KRTAP1-3 KRTAP5-4 KRTAP5-3 KRTAP5-7 KRTAP5-11 LCE2A | 8.22e-13 | 73 | 60 | 9 | int:LCE3D |
| Interaction | CHIC2 interactions | KRTAP5-9 KRTAP2-3 KRTAP2-4 KRTAP1-3 LCE5A LCE1C LCE1B LCE1F LCE3C | 8.22e-13 | 73 | 60 | 9 | int:CHIC2 |
| Interaction | NUFIP2 interactions | KRTAP5-9 KRTAP2-3 MEGF6 KRTAP2-4 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 PRKN LCE1B MEGF11 LCE1F KRTAP5-11 NOTCH3 LCE3C | 9.67e-13 | 417 | 60 | 15 | int:NUFIP2 |
| Interaction | SMCP interactions | KRTAP5-9 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 LCE1B LCE1F KRTAP5-7 KRTAP5-11 | 1.72e-12 | 79 | 60 | 9 | int:SMCP |
| Interaction | KRTAP1-1 interactions | SCARF1 KRTAP5-9 KRTAP2-3 KRTAP2-4 LCE5A KRTAP5-4 KRTAP5-3 LCE1B LCE1F KRTAP5-11 LCE2A LCE3C | 1.77e-12 | 219 | 60 | 12 | int:KRTAP1-1 |
| Interaction | RGS20 interactions | KRTAP5-9 CRCT1 LCE5A KRTAP5-4 KRTAP5-3 LCE1B LCE1F KRTAP5-11 LCE2A LCE3C | 1.89e-12 | 118 | 60 | 10 | int:RGS20 |
| Interaction | CATSPER1 interactions | KRTAP5-9 KRTAP2-3 KRTAP2-4 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 LCE1B LCE1F KRTAP5-11 | 3.68e-12 | 126 | 60 | 10 | int:CATSPER1 |
| Interaction | NBPF19 interactions | KRTAP5-9 KRTAP2-3 KRTAP13-3 KRTAP2-4 LCE5A KRTAP5-4 KRTAP5-3 LCE1B LCE1F KRTAP5-11 LCE2A LCE3C | 3.68e-12 | 233 | 60 | 12 | int:NBPF19 |
| Interaction | KRTAP10-6 interactions | KRTAP5-9 LCE5A KRTAP5-4 KRTAP5-3 LCE1B LCE1F KRTAP5-11 LCE2A LCE3C | 4.68e-12 | 88 | 60 | 9 | int:KRTAP10-6 |
| Interaction | KRTAP1-3 interactions | KRTAP5-9 CRCT1 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 LCE1B LCE1F KRTAP5-11 LCE2A LCE3C | 6.32e-12 | 184 | 60 | 11 | int:KRTAP1-3 |
| Interaction | KRTAP10-8 interactions | SCARF1 KRTAP5-9 CRCT1 KRTAP1-3 LCE5A KRTAP5-4 KRTAP5-3 KRTAP15-1 LCE1C LCE1B LCE1F KRTAP5-11 LCE2A LCE3C | 9.19e-12 | 401 | 60 | 14 | int:KRTAP10-8 |
| Interaction | KRTAP12-1 interactions | 1.30e-11 | 63 | 60 | 8 | int:KRTAP12-1 | |
| Interaction | TRIM42 interactions | KRTAP2-3 KRTAP2-4 LCE5A LCE1C LCE1B LCE1F KRTAP5-7 KRTAP5-11 LCE2A LCE3C | 1.98e-11 | 149 | 60 | 10 | int:TRIM42 |
| Interaction | KRTAP11-1 interactions | KRTAP5-9 KRTAP5-4 KRTAP5-3 KRTAP15-1 LCE1B LCE1F KRTAP5-11 LCE2A LCE3C | 3.06e-11 | 108 | 60 | 9 | int:KRTAP11-1 |
| Interaction | KRTAP5-7 interactions | 3.49e-11 | 71 | 60 | 8 | int:KRTAP5-7 | |
| Interaction | SPRY1 interactions | KRTAP5-9 MAP4K1 KRTAP1-3 LCE5A LCE1C LCE1B LCE1F LCE2A LCE3C | 3.92e-11 | 111 | 60 | 9 | int:SPRY1 |
| Interaction | NOTCH2NLA interactions | KRTAP5-9 KRTAP2-3 CRCT1 KRTAP13-3 KRTAP2-4 LCE5A KRTAP5-4 KRTAP5-3 LCE1B LCE1F KRTAP5-11 LCE2A LCE3C | 7.44e-11 | 381 | 60 | 13 | int:NOTCH2NLA |
| Interaction | KRTAP1-5 interactions | 9.67e-11 | 48 | 60 | 7 | int:KRTAP1-5 | |
| Interaction | ALPP interactions | 9.94e-11 | 123 | 60 | 9 | int:ALPP | |
| Interaction | POU4F2 interactions | KRTAP5-9 KRTAP13-3 LCE5A KRTAP5-4 KRTAP5-3 LCE1C LCE1F KRTAP5-11 | 1.26e-10 | 83 | 60 | 8 | int:POU4F2 |
| Interaction | KRTAP10-10 interactions | 1.52e-10 | 27 | 60 | 6 | int:KRTAP10-10 | |
| Interaction | KRTAP12-4 interactions | 2.00e-10 | 53 | 60 | 7 | int:KRTAP12-4 | |
| Interaction | KRTAP12-3 interactions | KRTAP5-9 CRCT1 KRTAP13-3 LCE5A LCE1C LCE1B LCE1F LCE2A LCE3C | 4.63e-10 | 146 | 60 | 9 | int:KRTAP12-3 |
| Interaction | CYP21A2 interactions | 5.60e-10 | 33 | 60 | 6 | int:CYP21A2 | |
| Interaction | VWC2 interactions | 6.25e-10 | 62 | 60 | 7 | int:VWC2 | |
| Interaction | ADAMTSL4 interactions | KRTAP5-9 LCE5A KRTAP5-4 KRTAP5-3 LCE1C LCE1B LCE1F KRTAP5-7 LCE2A LCE3C | 8.03e-10 | 217 | 60 | 10 | int:ADAMTSL4 |
| Interaction | KRTAP10-7 interactions | KRTAP5-9 CRCT1 LCE5A KRTAP5-4 KRTAP5-3 LCE1B LCE1F KRTAP5-11 LCE2A LCE3C | 1.44e-08 | 293 | 60 | 10 | int:KRTAP10-7 |
| Interaction | KRTAP4-1 interactions | 3.16e-08 | 31 | 60 | 5 | int:KRTAP4-1 | |
| Interaction | PHLDA1 interactions | 4.26e-08 | 66 | 60 | 6 | int:PHLDA1 | |
| Interaction | POTED interactions | 1.00e-07 | 4 | 60 | 3 | int:POTED | |
| Interaction | KRTAP12-2 interactions | 1.03e-07 | 128 | 60 | 7 | int:KRTAP12-2 | |
| Interaction | MBD1 interactions | 1.08e-07 | 77 | 60 | 6 | int:MBD1 | |
| Interaction | ZNF440 interactions | 1.20e-07 | 40 | 60 | 5 | int:ZNF440 | |
| Interaction | ZNF628 interactions | 1.26e-07 | 16 | 60 | 4 | int:ZNF628 | |
| Interaction | KRTAP3-2 interactions | 1.27e-07 | 79 | 60 | 6 | int:KRTAP3-2 | |
| Interaction | GRN interactions | 1.39e-07 | 281 | 60 | 9 | int:GRN | |
| Interaction | LELP1 interactions | 1.64e-07 | 17 | 60 | 4 | int:LELP1 | |
| Interaction | SDC3 interactions | 1.96e-07 | 44 | 60 | 5 | int:SDC3 | |
| Interaction | SHFL interactions | 4.32e-07 | 97 | 60 | 6 | int:SHFL | |
| Interaction | HHEX interactions | 5.58e-07 | 54 | 60 | 5 | int:HHEX | |
| Interaction | SPATA3 interactions | 7.21e-07 | 24 | 60 | 4 | int:SPATA3 | |
| Interaction | SLC39A7 interactions | 1.35e-06 | 187 | 60 | 7 | int:SLC39A7 | |
| Interaction | OIT3 interactions | 1.42e-06 | 65 | 60 | 5 | int:OIT3 | |
| Interaction | CRY2 interactions | 1.72e-06 | 194 | 60 | 7 | int:CRY2 | |
| Interaction | HOXB9 interactions | 1.83e-06 | 124 | 60 | 6 | int:HOXB9 | |
| Interaction | KPRP interactions | KRTAP5-9 KRTAP13-3 KRTAP1-3 KRTAP5-3 PRKN KRTAP15-1 KRTAP5-7 LCE3C | 1.91e-06 | 284 | 60 | 8 | int:KPRP |
| Interaction | FBLN1 interactions | 2.31e-06 | 129 | 60 | 6 | int:FBLN1 | |
| Interaction | POTEB3 interactions | 3.47e-06 | 35 | 60 | 4 | int:POTEB3 | |
| Interaction | WNT10A interactions | 4.36e-06 | 37 | 60 | 4 | int:WNT10A | |
| Interaction | ZNF672 interactions | 5.42e-06 | 12 | 60 | 3 | int:ZNF672 | |
| Interaction | SPRY2 interactions | 5.97e-06 | 152 | 60 | 6 | int:SPRY2 | |
| Interaction | DMRT3 interactions | 6.05e-06 | 87 | 60 | 5 | int:DMRT3 | |
| Interaction | POTEC interactions | 7.02e-06 | 13 | 60 | 3 | int:POTEC | |
| Interaction | KRTAP5-1 interactions | 7.02e-06 | 13 | 60 | 3 | int:KRTAP5-1 | |
| Interaction | KRTAP6-3 interactions | 8.30e-06 | 161 | 60 | 6 | int:KRTAP6-3 | |
| Interaction | CHRD interactions | 8.84e-06 | 94 | 60 | 5 | int:CHRD | |
| Interaction | IGSF5 interactions | 8.92e-06 | 14 | 60 | 3 | int:IGSF5 | |
| Cytoband | 1q21.3 | 2.86e-10 | 117 | 63 | 7 | 1q21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 8.52e-08 | 404 | 63 | 8 | chr1q21 | |
| Cytoband | 17q21.2 | 2.76e-06 | 70 | 63 | 4 | 17q21.2 | |
| Cytoband | 11p15.5 | 2.20e-05 | 118 | 63 | 4 | 11p15.5 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 4.79e-05 | 473 | 63 | 6 | chr17q21 | |
| Cytoband | 11q13.4 | 1.55e-04 | 75 | 63 | 3 | 11q13.4 | |
| Cytoband | Xq22 | 4.21e-04 | 22 | 63 | 2 | Xq22 | |
| Cytoband | 17q12-q21 | 8.95e-04 | 32 | 63 | 2 | 17q12-q21 | |
| Cytoband | 21q22.1 | 1.33e-03 | 39 | 63 | 2 | 21q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q13 | 3.55e-03 | 454 | 63 | 4 | chr11q13 | |
| Cytoband | 17p13.3 | 6.58e-03 | 88 | 63 | 2 | 17p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 7.58e-03 | 564 | 63 | 4 | chr11p15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr21q22 | 1.52e-02 | 377 | 63 | 3 | chr21q22 | |
| GeneFamily | Keratin associated proteins | KRTAP5-9 KRTAP2-3 KRTAP13-3 KRTAP2-4 KRTAP21-3 KRTAP1-3 KRTAP5-1 KRTAP5-4 KRTAP5-3 KRTAP5-10 KRTAP2-1 KRTAP2-2 KRTAP15-1 KRTAP5-5 KRTAP5-7 KRTAP5-11 | 1.86e-24 | 109 | 48 | 16 | 619 |
| GeneFamily | Late cornified envelope proteins | 4.59e-12 | 18 | 48 | 6 | 627 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 1.44e-04 | 7 | 48 | 2 | 785 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 5.28e-04 | 13 | 48 | 2 | 685 | |
| GeneFamily | Fibrinogen C domain containing | 1.99e-03 | 25 | 48 | 2 | 554 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 2.32e-03 | 27 | 48 | 2 | 1253 | |
| GeneFamily | Ankyrin repeat domain containing | 3.84e-03 | 242 | 48 | 4 | 403 | |
| GeneFamily | Fibronectin type III domain containing | 8.79e-03 | 160 | 48 | 3 | 555 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 5.34e-07 | 204 | 62 | 7 | MM966 | |
| Coexpression | JARDIM_PERASSI_TRIPLE_NEGATIVE_BREAST_CANCER_MOUSE_XENOGRAFT_MELATONIN_UP | 5.55e-06 | 49 | 62 | 4 | MM452 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 6.90e-06 | 16 | 62 | 3 | M2207 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 6.90e-06 | 16 | 62 | 3 | MM1296 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 5.64e-05 | 173 | 62 | 5 | M650 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_250 | 1.68e-05 | 206 | 56 | 6 | Facebase_ST1_Univ_250 | |
| CoexpressionAtlas | skin | 2.45e-05 | 456 | 56 | 8 | skin | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_500 | 1.26e-04 | 427 | 56 | 7 | Facebase_ST1_Univ_500 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | KRTAP5-9 KRTAP2-3 KRT28 KRTAP1-3 KRTAP5-1 KRTAP5-4 KRTAP5-3 KRTAP5-10 KRTAP2-1 KRTAP2-2 KRTAP5-5 KRTAP5-7 KRTAP5-11 | 2.33e-20 | 146 | 63 | 13 | 522c32103c24fc26836bb5b642083904682d9292 |
| ToppCell | Basal_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 3.81e-06 | 166 | 63 | 5 | 23c04d1fba0c1733ccd0e4378fae2edde4fd0a7b | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.33e-06 | 195 | 63 | 5 | 6c9c58322c1df891bb4bab56dacb542c8777bb7d | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 8.75e-06 | 197 | 63 | 5 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | Epithelial_cells-Basal_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 8.97e-06 | 198 | 63 | 5 | 4235005c49fc2b29ad3a0ee6b608f0109d04f775 | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma,_Immature_Teratoma,_Mature_Teratoma,_Yolk_Sac_Tumor-3|TCGA-Testes / Sample_Type by Project: Shred V9 | 2.98e-05 | 125 | 63 | 4 | 5f90de494b53ecce6455034f3ed5dccdbb2c29ca | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma-10|TCGA-Bladder / Sample_Type by Project: Shred V9 | 3.37e-05 | 129 | 63 | 4 | 6a201c6344a015e5cf2f79ccf397fd7ad66b6768 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.64e-05 | 140 | 63 | 4 | 7b359bfbd404ab06d799048252f4985d85852048 | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 6.39e-05 | 152 | 63 | 4 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-3|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 7.98e-05 | 161 | 63 | 4 | 52239a887799362256ecd7e740b716b88ed59a62 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 8.57e-05 | 164 | 63 | 4 | de1646dbcf2a10b48e021acf7dc63e803e6a47ce | |
| ToppCell | Basal_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 8.57e-05 | 164 | 63 | 4 | 85487a303194f5244956ec1ca2d1758d38117f41 | |
| ToppCell | Endothelial-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.01e-04 | 171 | 63 | 4 | 07ff7059071da83da1d8f266a586573920d75b58 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-04 | 173 | 63 | 4 | 61907116a1460bc157ba73b5edd108db7dd5de4b | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 173 | 63 | 4 | 0f9c1d3298e59e6d22bb3306f0f445f490be8bbd | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-04 | 173 | 63 | 4 | 85083b9ce20351dd69aa2327ad087b848b4307ff | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-04 | 174 | 63 | 4 | cc4c7f00a25a7814b52d4599166615daa140cc31 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-04 | 180 | 63 | 4 | 25f8e82bbc1853cb7d072484e99369c72779dd1e | |
| ToppCell | AT1-AT2_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.23e-04 | 180 | 63 | 4 | 3c7b2033821f9e34e2924bd8655f566edcbcc7d3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-04 | 181 | 63 | 4 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-04 | 182 | 63 | 4 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-04 | 184 | 63 | 4 | 7d41784eac0935e77d6bc701f20c693adf998730 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.42e-04 | 187 | 63 | 4 | ae2ee6f8e5c37cb88a67f3e742cf86e57657bfaf | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 1.42e-04 | 187 | 63 | 4 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.54e-04 | 191 | 63 | 4 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial-Intermediate_lymphatic_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.54e-04 | 191 | 63 | 4 | d25ac3206fe205a100cfee26431ff32c14c1938f | |
| ToppCell | wk_20-22-Endothelial-Lymph_endothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.54e-04 | 191 | 63 | 4 | 631f95fd80dd3678b5b2ef201abf7fe646049af6 | |
| ToppCell | Basal_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.54e-04 | 191 | 63 | 4 | a98915bad9a4a61dd4cbca798914849b805f4a19 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.57e-04 | 192 | 63 | 4 | 5388f3115ab285f3f3001af1d71543ed64b9e044 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Ndnf_(medial_geniculate_nucleus,_ventral_part_(MGV)?_Or_State?)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.58e-04 | 74 | 63 | 3 | c68b00cf7d2cec7951b78e2c6710d7770b02566a | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Ndnf_(medial_geniculate_nucleus,_ventral_part_(MGV)?_Or_State?)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.58e-04 | 74 | 63 | 3 | bad24c9251ef44c05f3390073732a467aaeefe1e | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Ndnf_(medial_geniculate_nucleus,_ventral_part_(MGV)?_Or_State?)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.58e-04 | 74 | 63 | 3 | 195fd37345a394c0b60f713bedadf6fd08dc050c | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Diffuse_Sclerosing-8|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.58e-04 | 74 | 63 | 3 | d7a7a946ef5a28bccd45e0ba4bc7a12e54f0cc64 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial-Lymphatic_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.64e-04 | 194 | 63 | 4 | bc03d0f8dca9f4ba10db2f2274293f8b119e8951 | |
| ToppCell | wk_20-22-Endothelial-Lymph_endothelial-Lymphatic_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.64e-04 | 194 | 63 | 4 | 640ff8da7084a9486fc2752493b8d8059ecf4ab7 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_venous_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.67e-04 | 195 | 63 | 4 | ca2cf2c10db1ad17aa0a2e30aa7079a7ad751ea6 | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.70e-04 | 196 | 63 | 4 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.70e-04 | 196 | 63 | 4 | ff627244d7f5fd6a2ec009dae32d3509f0e2d95e | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.74e-04 | 197 | 63 | 4 | f5d87824c0020c95d89e069fd9f70b49e5d5fcea | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.74e-04 | 197 | 63 | 4 | 107cb153ea7fc74bbd244dbb9d0499c0a8506724 | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.77e-04 | 198 | 63 | 4 | 10a17d7c116dcd6cf847fe6f5d7196d887cad1f9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-04 | 198 | 63 | 4 | fc00cb25cdc6c31b7f9d397bc9f9a8f4e9708003 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.77e-04 | 198 | 63 | 4 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-04 | 199 | 63 | 4 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.80e-04 | 199 | 63 | 4 | d95d78b2ebc9a20532466e4d4be579b4faf6776f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.80e-04 | 199 | 63 | 4 | cdcfca94baba66e213cc3ffb0cfb4c75d6ab44ec | |
| ToppCell | Biopsy_Other_PF-Epithelial-KRT5-/KRT17+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.84e-04 | 200 | 63 | 4 | 077e6b9340686de9d0f11b035a8954e1f6a1b790 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.84e-04 | 200 | 63 | 4 | 8c1d4fffa5abe89ee2ff84fed2dfa97c779bde04 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.84e-04 | 200 | 63 | 4 | 1026b4ede4ea61d01ea942164b37a08c8c8234ff | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.84e-04 | 200 | 63 | 4 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Basal_3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.84e-04 | 200 | 63 | 4 | 06b59ee536414d1f73c1e17cdfd7c3f2259b9bef | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.84e-04 | 200 | 63 | 4 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | (01)_IL1RL1+|World / shred by cell type by condition | 1.84e-04 | 200 | 63 | 4 | 501420901bf3ec1b050e0d14596a9f9f3fdfc928 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.84e-04 | 200 | 63 | 4 | 72c9cd872074b60f62685a95eab83c41e609eb6e | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4-_Ptgds_(Bmp4)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.85e-04 | 78 | 63 | 3 | 87ed71a692416a21c8c11b5adbfe629f7d57ddb4 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4-_Ptgds_(Bmp4)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.85e-04 | 78 | 63 | 3 | 9545ae56fda3893b82b5efa82082e1f585a5f92a | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Sc17a7.Calb1-Lpl-Penk_(Layer_2/3)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.22e-04 | 83 | 63 | 3 | b683c8496474b0df0042f596c9b0ea5916a2ab15 | |
| Drug | beta-damascenone | 4.76e-07 | 24 | 61 | 4 | ctd:C075388 | |
| Disease | cathepsin D measurement | 3.06e-06 | 15 | 57 | 3 | EFO_0010611 | |
| Disease | Glioblastoma | 1.69e-05 | 79 | 57 | 4 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 2.15e-05 | 84 | 57 | 4 | C0334588 | |
| Disease | intestinal cancer (implicated_via_orthology) | 3.26e-05 | 32 | 57 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | Glioblastoma Multiforme | 6.42e-05 | 111 | 57 | 4 | C1621958 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 7.65e-05 | 7 | 57 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 7.65e-05 | 7 | 57 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | atopic eczema | 1.27e-04 | 252 | 57 | 5 | EFO_0000274 | |
| Disease | monoclonal gammopathy | 1.49e-04 | 53 | 57 | 3 | EFO_0000203 | |
| Disease | tenascin measurement | 1.63e-04 | 10 | 57 | 2 | EFO_0008296 | |
| Disease | Malignant neoplasm of lung | 1.64e-04 | 266 | 57 | 5 | C0242379 | |
| Disease | clostridium difficile infection | 1.76e-04 | 144 | 57 | 4 | EFO_0009130 | |
| Disease | Malignant neoplasm of skin | 2.06e-04 | 59 | 57 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 2.06e-04 | 59 | 57 | 3 | C0037286 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 5.56e-04 | 195 | 57 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | triacylglycerol 58:9 measurement | 8.26e-04 | 22 | 57 | 2 | EFO_0010443 | |
| Disease | Squamous cell carcinoma of esophagus | 8.34e-04 | 95 | 57 | 3 | C0279626 | |
| Disease | Carcinoma, Pancreatic Ductal | 9.85e-04 | 24 | 57 | 2 | C0887833 | |
| Disease | brain cancer (implicated_via_orthology) | 1.16e-03 | 26 | 57 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | hair shape measurement | 1.25e-03 | 27 | 57 | 2 | EFO_0007824 | |
| Disease | hair morphology | 1.44e-03 | 29 | 57 | 2 | EFO_0005038 | |
| Disease | colorectal cancer (implicated_via_orthology) | 1.54e-03 | 30 | 57 | 2 | DOID:9256 (implicated_via_orthology) | |
| Disease | colorectal cancer (is_implicated_in) | 1.67e-03 | 121 | 57 | 3 | DOID:9256 (is_implicated_in) | |
| Disease | Lung Neoplasms | 1.73e-03 | 265 | 57 | 4 | C0024121 | |
| Disease | loneliness measurement | 1.80e-03 | 124 | 57 | 3 | EFO_0007865 | |
| Disease | myocardial infarction (is_marker_for) | 1.86e-03 | 33 | 57 | 2 | DOID:5844 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NGSSGCGRCHKSCTG | 181 | Q15303 | |
| FGGCLDNSSGSGCKS | 491 | Q9BZ76 | |
| SYGKPCGGQDCSGSC | 26 | Q14031 | |
| ACGCGCGSLHTDGDK | 66 | Q07021 | |
| DGFGACEGTLACSTC | 101 | P10109 | |
| SSSCCGSGRGCCGDS | 36 | Q9UGL9 | |
| RSSGCCCCGGGSQRS | 71 | Q9UGL9 | |
| SGCGSAGGCGSVSCC | 41 | Q9H8G2 | |
| AGGCGSVSCCGNANF | 46 | Q9H8G2 | |
| CTESSCFNGGTCVDG | 991 | Q04721 | |
| SCNNGGTCSPVDGSC | 451 | A6BM72 | |
| GRDLCGGCTGSSSAC | 701 | Q96RG2 | |
| CGGSVAGSEFSCALG | 36 | Q7Z3Y7 | |
| NSDGKTCNVCSGGGG | 256 | P21941 | |
| TCNVCSGGGGSSATD | 261 | P21941 | |
| VNGGTCVGSGASFSC | 761 | Q9Y219 | |
| CVGSGASFSCICRDG | 766 | Q9Y219 | |
| CGSTFSSLSYGGGCC | 6 | Q9BYT5 | |
| CGSTLSSLSYGGGCC | 6 | P0C7H8 | |
| GCCENCGISFSGDGT | 131 | Q9UIS9 | |
| GGTCSSDGMGFHCTC | 746 | Q9UM47 | |
| GGSCQDGVGSFSCSC | 861 | Q9UM47 | |
| GGTCVDGVNSFSCLC | 936 | Q9UM47 | |
| VPACSCSSCGSCGGS | 56 | Q6L8G5 | |
| CSSCGSCGGSKGDCG | 61 | Q6L8G5 | |
| ACSCSSCGSCGGSKG | 51 | Q6L8G4 | |
| CQTSSCGTGCGIGGG | 76 | Q8IUG1 | |
| CGSTFSSLSYGGGCC | 6 | Q9BYU5 | |
| CGSTLSSLSYGGGCC | 6 | Q9BYR9 | |
| GGGRSGTFCAICSVC | 1381 | O14522 | |
| CCRGSGTSNVGTSGD | 71 | A0JP26 | |
| CGHGTCIDGIGSFSC | 106 | P04070 | |
| DGSCGGAFAVAGCSV | 521 | P23508 | |
| GCGAGTDANRFSACS | 471 | Q9BYI3 | |
| GACVPASSCGCTFQG | 791 | Q9Y6R7 | |
| CQEGGLVSCESSSCG | 1216 | Q9Y6R7 | |
| SGVSCLTTCASGGEC | 1401 | Q5JV73 | |
| CCACKSETNGGNTGS | 21 | Q9H972 | |
| SCSSCGSCAGSKGGC | 216 | Q6L8H4 | |
| ACSCSSCGSCGGSKG | 51 | Q6L8H2 | |
| CCSSSCGSCGGSKGV | 96 | Q6L8H2 | |
| GSKGGCGSCGCSQCS | 116 | Q6L8H2 | |
| GSKGGCGSCGCSQCS | 186 | Q6L8H1 | |
| QSSGCCSQPSGGSSC | 91 | Q5T7P3 | |
| SCGVSKGACGSCGGS | 101 | Q701N2 | |
| KGGCGSYGCSQSSCC | 146 | Q701N2 | |
| QSSGCCSQPSGGSSC | 91 | Q5T751 | |
| ACSCSSCGSCGGSKG | 51 | Q6L8G8 | |
| CSQPSAGSSCCGGGS | 96 | Q5T754 | |
| GCDSSCGSCGSGCRG | 16 | P26371 | |
| EPSGGSGCCHSSGDC | 91 | Q5TA79 | |
| SGGCGPSSESGCCLS | 41 | Q5T5A8 | |
| GFGSNSCCSLSCGSR | 101 | Q3SY46 | |
| SGGCCSSEGGGCCLS | 56 | Q5TCM9 | |
| GCGSTGFQSLDCGSS | 106 | Q3LI76 | |
| KSVCGSCGFGSCYGC | 6 | Q3LHN1 | |
| GSGGSCPAVCDCTSQ | 26 | Q6UY18 | |
| CCRGSGTSNVGTSGD | 71 | B2RU33 | |
| GCRACCVAEGASSGG | 606 | Q92918 | |
| GKNCSFSCSCQNGGT | 561 | O75095 | |
| FGVNCSSSCSCGGAP | 736 | O75095 | |
| CCRGSGTSNVGTSGD | 71 | Q86YR6 | |
| SSASGAAGCCCASSG | 131 | Q15464 | |
| AAGCCCASSGAGAAA | 136 | Q15464 | |
| TCEGGNGLGCGFAFC | 351 | O60260 | |
| GGHGSCIDGNCVCSA | 646 | Q9NT68 | |
| GSCDTVTGDCVCSAG | 361 | Q14162 | |
| CCSFSTDGGSLATGG | 2066 | Q99973 | |
| CTGGCCPASAQAGTG | 121 | P22105 | |
| CSGRGNFSTEGCGCV | 161 | P24821 | |
| HTSTGGGFCDCGDTE | 141 | Q8IWV7 | |
| EGNGTCSCQEGFGGT | 131 | Q8WWQ8 | |
| CSCQEGFGGTACETC | 136 | Q8WWQ8 | |
| GSSGCCENSGSSGCC | 196 | Q5T750 | |
| CENSGSSGCCGSGGC | 201 | Q5T750 | |
| SCSACGKCFGGSGDL | 536 | Q6ZSB9 | |
| ISCSNGFGGEGCEAT | 246 | Q8NA23 | |
| TTSGGGGFCDCGDTE | 141 | Q8IWV8 | |
| GFAVTGCTCGSACGS | 66 | Q9HD89 | |
| AGGQAFRCGSCDGSF | 381 | Q5EBL2 |